Richard D. Klausner is an American scientist who served as the 11th director of the National Cancer Institute of the United States.
Richard Klausner | |
|---|---|
 | |
| 11th Director of the National Cancer Institute | |
| In office August 1, 1995 – September 30, 2001 | |
| President | Bill Clinton George W. Bush |
| Preceded by | Samuel Broder |
| Succeeded by | Andrew C. von Eschenbach |
| Personal details | |
| Children | 4 |
| Alma mater | |
| Scientific career | |
| Institutions | |
Early life and education
editKlausner was born in 1950 or 1951.[1] His father was a chemist, and Klausner would visit his father's laboratory as a child. He began studying physics at Yale University, but changed his focus to biology, with the plan of becoming a doctor in a rural area.[1] Klausner received his MD from Duke Medical School in 1976.[2]
Career
editIn 1979, Klausner joined the National Institutes of Health (NIH) as a postdoctoral fellow. At age 30, Klausner was appointed to the chief of the cell biology and metabolism branch of the National Institute of Child Health and Human Development.[1]
In 1992, he directed the review of the NIH's intramural research programs, in which he recommended sweeping changes.[1] He served as the director of the National Cancer Institute from 1995 to 2001, where he managed a staff of 5,000 employees and a budget of $4.5 billion.[3] In total, he spent more than 20 years at the NIH.[4]
He left the NCI to become the founding director of the Case Institute of Health, Science and Technology of the Case Foundation.[4][5]
He was the managing partner of the biotech venture capital firm, the Column Group.[6] From 2002 to 2005, he was the executive director of the Bill & Melinda Gates Foundation.[3][7]
He was a member of the Searle Scholars advisory board.[8] He was a scientific advisor at the Fred Hutchinson Cancer Research Center.[9] He has been an Advisor to the Presidents of the Academies for counter-terrorism and a liaison to the White House Office of Science & Technology Policy,[6] and was the chief strategy advisor for USAID.[10]
Klausner co-founded Juno Therapeutics in 2013, GRAIL in 2015.[11][12] and MindStrong Health in 2014. He was the chief medical officer of Illumina from 2013 to 2016.[13]
In 2022, Klausner co-founded Altos Labs and is currently Chief Scientist and Board Co-Chairman of the company.[14]
He was president of the American Society for Clinical Investigation from 1995 to 1996.[12]
Research
editHis research focused on T cells and the potential for CAR-T therapies.[15] He also has published research on the genetics of Von Hippel–Lindau disease, a condition which predisposes a person to developing cancer.[9] He is an author of more than 300 scientific articles.[6]
Personal life
editKlausner has two sons and twin daughters.[1]
Awards
edit- 1986 Elected to the American Society for Clinical Investigation (ASCI)[16]
- 1993 Elected to the National Academy of Sciences[17]
- 1995 Elected to the American Academy of Arts and Sciences[12]
- 1997 Dickson Prize in Medicine, University of Pittsburgh[12]
- 1998 Raymond Bourgine Award for Excellence in Cancer Research and Gold Medal of Paris[12]
- 1999 ASCI Stanley J. Korsmeyer Award[16]
- 2000 Medal of Honour, International Agency for Research on Cancer[11]
- 2018 Elected fellow of the American Association for Cancer Research[12]
References
edit- ^ a b c d e Kolata, Gina (12 December 1995). "SCIENTIST AT WORK: Richard Klausner;New Administrator Is 'Not an Administrator'". The New York Times. Retrieved 6 May 2019.
- ^ Ltd, BMJ Publishing Group (1 November 2001). "Richard Klausner Steps Down as NCI Director". Journal of Investigative Medicine. 49 (6): 469. doi:10.2310/6650.2001.33610. ISSN 1081-5589. S2CID 219542301. Retrieved 6 May 2019.
- ^ a b "Dr. Richard D. Klausner Named Executive Director of Global Health for Bill & Melinda Gates Foundation". Bill & Melinda Gates Foundation. Retrieved 6 May 2019.
- ^ a b "NCI Director Richard Klausner Will Leave NIH - National Cancer Institute". 1 August 2012. Archived from the original on 2012-08-01. Retrieved 6 May 2019.
- ^ "NIH Record-10/02/2001--Klausner Leaves NIH to Head New Institute". nihrecord.nih.gov. Retrieved 6 May 2019.
- ^ a b c "Richard Klausner – Juno Therapeutics". www.junotherapeutics.com. Retrieved 6 May 2019.
- ^ Paulson, Tom; Reporter, Seattle Post-Intelligencer (13 September 2005). "Gates Foundation's global health chief leaving". seattlepi.com. Retrieved 6 May 2019.
- ^ "Searle Scholars Program : Richard D. Klausner (Advisory Board)". www.searlescholars.net. Retrieved 6 May 2019.
- ^ a b "Richard Klausner, ex-NCI head, joins center as senior adviser". Fred Hutch. 17 October 2002. Retrieved 6 May 2019.
- ^ "Richard Klausner, MD, Senior VP and CMO, Illumina". Rosenman Institute. Retrieved 6 May 2019.
- ^ a b "Dr Richard Klausner – IARC". www.iarc.fr. Retrieved 6 May 2019.
- ^ a b c d e f "Richard D. Klausner, MD". www.aacr.org. Retrieved 6 May 2019.
- ^ "Illumina Taps Phil Febbo to Oversee Precision Medicine Strategy as CMO". Clinical OMICs - Molecular Diagnostics in Personalized Medicine. 13 March 2018. Retrieved 6 May 2019.
- ^ "Rick Klausner, Founder, Chief Scientist and Board Co-Chairman". altoslabs.com. Retrieved 15 Jan 2024.
- ^ "Richard Klausner, M.D. – LifeMine". lifeminetx.com. 6 June 2017. Retrieved 6 May 2019.
- ^ a b "The American Society for Clinical Investigation". Retrieved 6 May 2019.
- ^ "Richard Klausner". www.nasonline.org. Retrieved 6 May 2019.